Such results are consistent with the concept that SLFN12 is prognostically favorable in lung adenocarcinoma, because higher levels of TTF-1 are associated with favorable prognosis in non-squamous NSCLC [8]. This evidence concerns the gene SLFN12 and lung adenocarcinoma.